title: Reply to "therapeutic outcomes of pyogenic vertebral osteomyelitis requiring spinal instrumentation".
authors.affiliation: Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
authors.forename: Ryan
authors.initials: R
authors.lastname: Arnold
authors.affiliation: Department of Epidemiology and Public Health, School of Medicine, University of Maryland, Baltimore, Maryland, USA clarerock@hotmail.com dmorgan@epi.umaryland.edu.
authors.forename: Clare
authors.initials: C
authors.lastname: Rock
authors.affiliation: Department of Epidemiology and Public Health, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Croft
authors.affiliation: Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Maryland, Baltimore, Maryland, USA Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Gilliam
authors.affiliation: Department of Epidemiology and Public Health, School of Medicine, University of Maryland, Baltimore, Maryland, USA VA Maryland Healthcare System, Baltimore, Maryland, USA clarerock@hotmail.com dmorgan@epi.umaryland.edu.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Morgan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009984:Orthopedic Fixation Devices / Q000382:microbiology*; D010019:Osteomyelitis / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents